Intergalactic Therapeutics
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Intergalactic researched non-viral gene therapies, using electric fields to deliver DNA into cells.
02 / Intergalactic Therapeutics FAILURE REASONS
Failure reasons
Reporting and an employee’s account identify insufficient development funding amid a difficult fundraising environment. The spokeswoman confirmed all-staff layoffs and a search for strategic options. Her statement that programs remained promising does not establish clinical efficacy, and the shutdown is not presented as a proven clinical-trial failure.
03 / EVENT HISTORY
Events in the structured record
- Company established
The startup was established to develop a different gene-delivery approach.
- All staff laid off; options sought
An August report confirmed layoffs and the decision to restructure and explore strategic options.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Research required further development capital
- 02
Funding was difficult to obtain
- 03
All staff laid off and strategic options sought